Potential role of phospholipases in virulence and fungal pathogenesis

Clinical Microbiology Reviews

Volumn 13, Issue 1, 2000, Pages 122-143

  Ghannoum, Mahmoud A ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; FLUCONAZOLE; LYSOPHOSPHOLIPASE; PHOSPHOLIPASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BACILLUS CEREUS; CANDIDA ALBICANS; CLOSTRIDIUM PERFRINGENS; CORYNEBACTERIUM; DIAGNOSTIC VALUE; ENZYME MECHANISM; ENZYME PURIFICATION; ENZYME SPECIFICITY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; LISTERIA MONOCYTOGENES; MOLECULAR CLONING; MOUSE; MYCOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PATHOPHYSIOLOGY; PSEUDOMONAS AERUGINOSA; RICKETTSIA; VIRULENCE;

ANIMALIA; ASPERGILLUS FUMIGATUS; BACILLUS CEREUS; CANDIDA ALBICANS; CANDIDA GLABRATA; CLOSTRIDIUM PERFRINGENS; CORYNEBACTERIUM; FILOBASIDIELLA NEOFORMANS; FUNGI; LISTERIA MONOCYTOGENES; MURINAE; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; RICKETTSIA;

EID: 0033958143     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/CMR.13.1.122-143.2000     Document Type: Article

References (231)

1. Abrehem, K., and I. Zamiri. 1980. Purification of a protein toxin from Corynebacterium ulcerans. J. Med. Microbiol. 13:587-592.
2. Aisner, J., S. C. Schimpff, J. C. Sutherland, V. M. Young, and P. H. Wiernik. 1976. Torulopsis glabrata infections in patients with cancer: increasing incidence and relationship to colonization. Am. J. Med. 61:23-28.
3. Alouf, J. E. 1977. Cell membranes and cytolytic bacterial toxins, p. 219-270. In P. Cuatrecasas (ed.), The specificity and action of animal, bacterial and plant toxins. Receptors and recognition, series B, vol. 1. John Wiley & Sons, Inc., New York, N.Y.
4. Ansell, G. B., and J. N. Hawthorne. 1964. Catabolism, p. 152-174. In G. B. Ansell and J. N. Hawthorne (ed.), Phospholipids. Elsevier Publishing Co., Amsterdam, The Netherlands.
5. Avigad, G. 1976. Microbial phospholipases, p. 99-167. In A. W. Bernheimer (ed.), Mechanisms in bacterial toxinology. John Wiley & Sons, Inc., New York, N.Y.
6. Awad, M. M., A. E. Bryant, D. L. Stevens, and J. I. Rood. 1995. Virulence studies on chromosomal α-toxin and θ-toxin mutants constructed by allelic exchange provide genetic evidence for the essential role of α-toxin in Clostridium perfringens-mediated gas gangrene. Mol. Microbiol. 15:191-202.
7. Bailey, J. E., R. M. Kliegman, W. L. Annable, B. B. Dahms, and A. A. Fanaroff. 1984. Torulopsis glabrata sepsis appearing as necrotizing enterocolitis and endophthalmitis. Am. J. Dis. Child. 183:965-966.
8. Baine, W. B. 1988. A phospholipase C from the Dallas 1E strain of Legionella pneumophila serogroup 5: purification and characterization of conditions for optimal activity with an artificial substrate. J. Gen. Microbiol. 134:489-498.
9. Banerjee, S. N., T. G. Emori, D. H. Culver, R. P. Gaynes, W. R. Jarvis, T. Horan, J. E. Edwards, J. Tolson, T. Henderson, W. J. Martone and National Nosocomial Infections Surveillance System. 1995. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989, p. 3-8. In J. Rex and M. D. Anderson (ed.), Serious Candida infections: risk factors, treatment, and prevention. Selected readings: focus on fluconazole. Medical Information Press, Pfizer, Inc., New York, N.Y.
10. Banno, Y., T. Yamada, and Y. Nozawa. 1985. Secreted phospholipases of the dimorphic fungus, Candida albicans; separation of three enzymes and some biological properties. Sabouraudia 23:47-54.
11. Barrett-Bee, K., Y. Hayes, R. G. Wilson, and J. F. Ryley. 1985. A comparison of phospholipase activity, cellular adherence and pathogenicity of yeasts. J. Gen. Microbiol. 131:1217-1221.
12. Beck-Sagué, C. M., W. R. Jarvis, and National Nosocomial Infections Surveillance System. 1993. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. J. Infect. Dis. 167: 1247-1251.
13. Berka, R., G. Gray, and M. Vasil. 1981. Studies of phospholipase C (heat-labile haemolysin) in Pseudomonas aeruginosa. Infect. Immun. 34:1071-1074.
14. Berka, R., and M. Vasil. 1982. Phospholipase C (heat-labile hemolysin) of Pseudomonas aeruginosa: purification and preliminary characterization. J. Bacteriol. 152:239-245.
15. Bernheimer, A. W., and R. F. Bey. 1986. Copurification of Leptospira interrogans serovar pomona hemolysin and sphingomyelinase C. Infect. Immun. 54:262-264.
16. Birch, M., G. Robson, D. L. Law, and D. W. Denning. 1996. Evidence of multiple extracellular phospholipase activities of Aspergillus fumigatus. Infect. Immun. 64:751-755.
17. Bowman, M. H., A. C. Ottolenghi, and C. E. Mengel. 1972. The effects of phospholipase C on human erythrocytes. J. Med. Microbiol. 5:467-472.
18. Bryant, A. E., and D. L. Stevens. 1996. Phospholipase C and perfringolysin O from Clostridium perfringens upregulate endothelial cell-leukocyte adherence molecule 1 and intercellular leukocyte adherence molecule 1 expression and induce interleukin-8 synthesis in cultured human umbilical vein endothelial cells. Infect. Immun. 64:358-362.
19. Bunting, M., D. E. Lorant, A. E. Bryant, G. A. Zimmerman, T. M. McIntyre, D. L. Stevens, and S. M. Prescott. 1997. Alpha toxin from Clostridium perfringens induces proinflammatory changes in endothelial cells. J. Clin. Investig. 100:565-574.
20. Calderone, R., and P. Braun. 1991. Adherence and receptor relationships of Candida albicans. Microbiol. Rev. 55:1-20.
21. Camilli, A., H. Goldfine, and D. A. Portnoy. 1991. Listeria monocytogenes mutants lacking phosphatidylinositol-specific phospholipase C are avirulent. J. Exp. Med. 173:751-754.
22. Caro, L. H. P., H. Tettelin, J. H. Vossen, A. F. Ram, H. van den Ende, and F. M. Klis. 1997. In silicio identification of glycosyl-phosphatidylinositol-anchored plasma-membrane and cell wall proteins of Saccharomyces cerevisiae. Yeast 13:1477-1489.
23. Chen, S., M. Muller, Z. Zhou, L. Wright, and T. Sorrell. 1997. Phospholipase activity in Cryptococcus neoformans: a new virulence factor? J. Infect. Dis. 175:414-420.
24. Chen, S., L. C. Wright, R. T. Santangelo, M. Muller, V. R. Moran, P. W. Kuchel, and T. C. Sorrell. 1997. Identification of extracellular phospholipase B. lysophospholipase, and acyltransferase produced by Cryptococcus neoformans. Infect. Immun. 65:405-411.
25. Chuck, S. L., and M. A. Sande. 1989. Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N. Engl. J. Med. 321: 794-799.
26. Reference deleted.
27. Reference deleted.
28. Cole, G. T., K. T. Lynn, and K. R. Seshan. 1990. An animal model for oropharyngeal, esophageal and gastric candidosis. Mycoses 33:7-19.
29. Coleman, K., G. Dougan, and J. P. Arbuthnott. 1983. Cloning and expression in Escherichia coli K12, of the chromosomal hemolysin (phospholipase C) determinant of Pseudomonas aeruginosa. J. Bacteriol. 153:909-915.
30. Costa, A., C. Costa, A. Misefari, and A. Amato. 1968. On the enzymatic activity of certain fungi. VII. Phosphatidase activity on media containing sheep's blood of pathogenic strains of Candida albicans. Atti Soc. Sci. Fis. Mat. Nat. XIV:93-101.
31. Reference deleted.
32. Reference deleted.
33. Cutler, J. E. 1991. Putative virulence factors of Candida albicans. Annu. Rev. Microbiol. 45:187-218.
34. Cutter, D., and A. Kreger. 1990. Cloning and expression of the damselysin gene from Vibrio damsela. Infect. Immun. 58:266-268.
35. Dennis, E. A., S. G. Rhee, M. M. Billah, and Y. A. Hannun. 1991. Role of phospholipases in generating lipid second messengers in signal transduction. FASEB J. 5:2068-2077.
36. De Silva, N. S., and P. A. Quinn. 1987. Rapid screening for phospholipase C activity in mycoplasmas. J. Clin. Microbiol. 25:729-731.
37. Diez-Orejas, R., G. Molero, F. Navarro-Garcia, J. Pla, C. Nombela, and M. Sanchez-Perez. 1997. Reduced virulence of Candida albicans MKC1 mutants: a role for mitogen-activated protein kinase in pathogenesis. Infect. Immun. 65:833-837.
38. Doery, H. M., B. J. Magnusson, J. Gulasekharam, and J. E. Pearson. 1965. The properties of phospholipase enzymes in staphylococcal toxins. J. Gen. Microbiol. 40:283-296.
39. Reference deleted.
40. Eckmann, L., S. L. Reed, J. R. Smith, and M. F. Kagnoff. 1995. Entamoeba histolytica trophozoites induce an inflammatory cytokine response by cultured human cells through the paracrine action of cytolytically released interleukin-1α. J. Clin. Investig. 96:1269-1279.
41. Ella, K. M., J. W. Dolan, C. Qi, and K. E. Meier. 1996. Characterization of Saccharomyces cerevisiae deficient in expression of phospholipase D. Biochem. J. 314:15-19.
42. Eng, R. H. K., E. Bishburg, and S. M. Smith. 1986. Cryptococcal infections in patients with acquired immune deficiency syndrome. Am. J. Med. 81: 19-23.
43. Englund, P. T. 1993. The structure and biosynthesis of glycosyl phosphatidylinositol protein anchors. Annu. Rev. Biochem. 62:121-138.
44. Exton, J. H. 1997. New developments in phospholipase D. J. Biol. Chem. 272:15579-15582.
45. Falkow, S. 1988. Molecular Koch's postulates applied to microbial pathogenicity. Rev. Infect. Dis. 10:S274-S276.
46. Flahaut, M. L., D. Sanglard, M. Monod, J. Bille, and M. Rossier. 1998. Rapid detection of Candida albicans in clinical sample by DNA amplification of common regions from C. albicans-secreted aspartic proteinase genes. J. Clin. Microbiol. 36:395-401.
47. Fonzi, F., and M. Y. Irwin. 1998. Isogenic strain construction and gene mapping in Candida albicans. Genetics 134:717-728.
48. Freer, J. H., and J. P. Arbuthnott. 1976. Biochemical and morphologic alterations of membranes by bacterial toxins, p. 169-193. In A. W. Bernheimer (ed.), Mechanisms of bacterial toxicology. John Wiley & Sons, Inc., New York, N.Y.
49. Fu, Y., A. Ibrahim, F. Fonzi, X. Zhou, C. Ramos, and M. Ghannoum. 1997. Cloning and characterization of a gene (LIP1) which encodes a lipase from the pathogenic yeast Candida albicans. Microbiology 143:340.
50. Gale, C. A., C. M. Bendel, M. McClellan, M. Hauser, J. M. Becker, J. Berman, and M. K. Hostetter. 1998. Linkage of adhesion, filamentous growth, and virulence in Candida albicans to a single gene, INT1. Science 279:1355-1358.
51. Gassama-Diagne, A., P. Rogalle, J. Fauvel, M. Willson, A. Klaébè, and H. Chaps. 1992. Substrate specificity of phospholipase B from guinea pig intestine. J. Biol. Chem. 267:13418-13424.
52. Georgopapadakou, N. H., and T. J. Walsh. 1996. Antifungal Agents: chemotherapeutic targets and immunologic strategies. Antimicrob. Agents Chemother. 40:279-291.
53. Gerber, L. D., K. Kodukula, and S. Udenfriend. 1992. Phosphatidylinositol glycan (PI-G) anchored membrane proteins. Amino acid requirements adjacent to the site of cleavage and PI-G attachment in the COOH-terminal signal peptide. J. Biol. Chem. 267:12168-12173.
54. Ghannoum, M., and K. H. Abu-Elteen. 1990. Pathogenicity determinants in Candida: a review. J. Mycol. Med. 33:265-282.
55. Ghannoum, M., and S. Radwan. 1990. Candida adherence to epithelial cells. CRC Press, Inc., Boca Raton, Fla.
56. Ghannoum, M. A. 1998. Extracellular phospholipases as universal virulence factor in pathogenic fungi. Jpn. J. Med. Mycol. 39:55-59.
57. Ghannoum, M. A., S. G. Filler, A. S. Ibrahim, Y. Fu, and J. E. Edwards, Jr. 1992. Modulation of interactions of Candida albicans and endothelial cells by fluconazole and amphotericin B. Antimicrob. Agents Chemother. 36: 2239-2244.
58. Ghannoum, M. A., B. J. Spellberg, S. M. Saporito-Irwin, and W. Fonzi. 1995. Reduced Virulence of Candida albicans PHR1 mutants. Infect. Immun. 63:4528-4530.
59. Gilmore, M. S., A. L. Cruz-Rodgz, M. Leimeister-Wachter, J. Kreft, and W. Goebel. 1989. A Bacillus cereus cytolytic determinant, cereolysin AB, which comprises the phospholipase C and sphingomyelinase genes: nucleotide sequence and genetic linkage. J. Bacteriol. 171:744-753.
60. Reference deleted.
61. Gow, N. A. R., P. W. Robbins, J. Lester, A. Brown, F. Fonzi, T. Chapman, and O. Kinsman. 1994. A hyphal-specific chitin synthase gene (CHS2) is not essential for growth, dimorphism, or virulence of Candida albicans. Proc. Natl. Acad. Sci. USA 91:6216-6220.
62. Granstrom, M., A. Erickson, B. Strandvik, B. Wretlind, O. Pavlovskis, R. Berka, and M. Vasil. 1984. Relationship between antibody response to Pseudomonas aeruginosa exoproteins and colonization/infection in patients with cystic fibrosis. Acta Paediatr. Scand. 73:772-777.
63. Graybill, J. R., E. Montalbo, W. R. Kirkpatrick, M. F. Luther, S. G. Revankar, and T. F. Patterson. 1998. Fluconazole versus Candida albicans: a complex relationship. Antimicrob. Agents Chemother. 42:2938-2942.
64. Habermann, E., and K. L. Hardt. 1972. A sensitive and specific plate test for the quantitation of phospholipases. Anal. Biochem. 50:163-173.
65. Hänel, H., R. Kirsch, H.-L. Schmidts, and H. Kottmann. 1995. New systematically active antimycotics from the beta-blocker category. Mycoses 38:251-264.
66. Hänel, H., I. Menzel, and H. Holzmann. 1988. High phospholipase A activity of Candida albicans isolated from the intestine of psoriatic patients. Mycoses 31:451-453. (In German.)
67. Hauschild, A. H. W., M. J. Walcroft, and W. Campbell. 1971. Emesis and diarrhea induced by enterotoxin of Clostridium perfringens type A in monkeys. Can. J. Microbiol. 17:1141-1143.
68. Henner, D. J., M. Yang, E. Chen, R. Hellmiss, H. Rodriguez, and M. G. Low. 1988. Sequence of the Bacillus thuringiensis phosphatidylinositol-specific phospholipase C. Nucleic Acids Res. 16:10383.
69. Hodgson, A. L. M., J. Krywult, L. A. Corner, J. S. Rothel, and A. J. Radford. 1992. Rational Attenuation of Corynebacterium pseudotuberculosis: potential cheesy gland vaccine and live delivery vehicle. Infect. Immun. 60:2900-2905.
70. Hoover, C. I., M. J. Jantapour, G. Newport, N. Agabian, and S. J. Fischer. 1998. Cloning and regulated expression of the Candida albicans phospholipase B (PLB1) gene. FEMS Microbiol. Lett. 167:163-169.
71. Howlett, J. A., and C. A. Squier. 1980. Candida albicans ultrastructure: colonization and invasion of oral epithelium. Infect. Immun. 29:252-260.
72. Hube, B. 1996. Candida albicans secreted aspartyl proteinases. Curr. Top. Med. Mycol. 7:55-69.
73. Hube, B. 1998. Possible role of secreted proteinases in Candida albicans infections. Rev. Iberoam. Micol. 15:65-68.
74. Hube, B., M. Monod, M. Monod, D. Sanglard and F. Odds. 1998. Functional aspects of secreted Candida proteinases, p. 339-344. In M. N. G. James (ed.), Aspartic proteinases. Plenum Press, New York, N.Y.
75. Hube, B., D. Sanglard, F. Odds, D. Hess, M. Monod, W. Schafer, A. J. P. Brown, and N. A. R. Gow. 1997. Disruption of each of the secreted aspartyl proteinase genes SAP1, SAP2, and SAP3 of Candida albicans attenuates virulence. Infect. Immun. 65:3529-3538.
76. Ibrahim, A. S., F. Mirbod, S. G. Filler, Y. Banno, G. T. Cole, Y. Kitajima, J. E. Edwards, Jr., Y. Nozawa, and M. A. Ghannoum. 1995. Evidence implicating phospholipase as a virulence factor of Candida albicans. Infect. Immun. 63:1993-1998.
77. Ikezawa, H. 1986. The physiological action of bacterial phosphatidylinositol-specific phospholipase C. The release of ectoenzymes and other effects. J. Toxicol. Toxin Rev. 5:1-24.
78. Ikezawa, H., M. Matsushita, M. Tomita, and R. Taguchi. 1986. Effects of metal ions on sphingomyelinase activity of Bacillus cereus. Arch. Biochem. Biophys. 249:588-595.
79. Ikezawa, H., T. Nakabayashi, K. Suzuki, M. Nakajima, T. Taguchi, and R. Taguchi. 1983. Complete purification of a phosphatidylinositol-specific phospholipase C from a strain of Bacillus thuringiensis. J. Biochem. 93: 1717-1719.
80. Ispolatovskaya, M. V. 1971. Type A Clostridium perfringens toxin, p. 109-158. In S. Kadis, T. C. Montie, and S. J. Ajl (ed.), Microbial toxins, vol. IIA. Bacterial protein toxins. Academic Press, Inc., New York, N.Y.
81. Jackson, S. G. 1989. Development of a fluorescent immunodot assay for Bacillus cereus enterotoxin. J. Immunol. Methods 120:215-220.
82. ®): a molecular rationale for the attenuation of amphotericin B related toxicities. J. Liposome Res. 3:451-471.
83. Reference deleted.
84. Johansen, K. A., R. E. Gill, and M. L. Vasin. 1996. Biochemical and molecular analysis of phospholipase C and phospholipase D activity in mycobacteria. Infect. Immun. 64:3259-3266.
85. Johansen, T., H. Haugli, H. Ikezawa, and C. Little. 1988. Bacillus cereus strain SE-1: nucleotide sequence of the sphingomyelinase C gene. Nucleic Acids Res. 16:10370.
86. Johansen, T., T. Holm, P. H. Guddal, K. Sletten, F. B. Haugli, and C. Little. 1988. Cloning and sequencing of the gene encoding the phosphatidylcholine-preferring phospholipase C of Bacillus cereus. Gene 65:293-304.
87. Kameyama, S., H. Sato, and R. Murata. 1975. The role of α-toxin of Clostridium perfringens in experimental gas gangrene in guinea pigs. Jpn. J. Med. Sci. Biol. 25:200.
88. Kanoh, H., S. Nakashima, Y. Zhao, Y. Sugiyama, Y. Kitajima, and Y. Nozawa. 1998. Molecular cloning of a gene encoding phospholipase D from the pathogenic and dimorphic fungus, Candida albicans. Biochim. Biophys. Acta 1398:359-364.
89. Kaplanski, G., N. Teysseire, C. Farnarier, S. Kaplanski, J. Lissitzky, J. Durand, J. Soubeyrand, C. A. Dinarello, and P. Bongard. 1995. IL-6 and IL-8 production from cultured human endothelial cells stimulated by infection with Rickettsia conorii via a cell-associated IL-1 alpha-dependent pathway. J. Clin. Investig. 96:2839-2844.
90. Kaufmann, C. S., and W. G. Merz. 1989. Electrophoretic karyotypes of Torulopsis glabrata. J. Clin. Microbiol. 27:2165-2168.
91. Klotz, S. 1992. Fungal adherence to the vascular compartment: a critical step in the pathogenesis of disseminated candidiasis. Clin. Infect. Dis. 14:340-347.
92. Klotz, S. A., D. J. Drutz, J. L. Harrison, and M. Huppert. 1983. Adherence and penetration of vascular endothelium by Candida yeasts. Infect. Immun. 42:374-384.
93. Komshian, S. V., A. K. Uwaydah, J. D. Sobel, and L. R. Crane. 1989. Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing outcome. Rev. Infect. Dis. 11:379-390.
94. Reference deleted.
95. Kozak, M. 1987. An analysis of 5′-encoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res. 15:8125-8148.
96. Kramer, J. M., and G. Gilbert. 1989. Bacillus cereus and other Bacillus species, p. 21-70. In M. P. Doyle (ed.), Foodborne bacterial pathogens. Marcel Dekker, Inc., New York, N.Y.
97. Kuppe, A., L. M. Evans, D. A. McMillen, and O. H. Griffith. 1989. Phosphatidylinositol-specific phospholipase C of Bacillus cereus: cloning, sequencing, and relationship to other phospholipases. J. Bacteriol. 171:6077-6083.
98. Kuppe, A., K. K. Hedberg, J. J. Volwerk, and O. H. Griffith. 1990. Inhibition of the phosphatidylinositol-specific phospholipase C from Bacillus cereus by a monoclonal antibody binding to a region with sequence similarity to eukaryotic phospholipases. Biochim. Biophys. Acta 1047:41-48.
99. Kyte, J., and R. F. Doolittle. 1982. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157:105-132.
100. Lane, T., and J. R. Garcia. 1991. Phospholipase production in morphological variants of Candida albicans. Mycoses 34:217-220.
101. Lee, K. S., J. L. Patton, M. Fido, L. K. Hines, S. D. Kohlwein, F. Paltauf, S. A. Henry, and D. E. Levin. 1994. The Saccharomyces cerevisiae PLB1 gene encodes a protein required for lysophospholipase and phospholipase B activity. J. Biol. Chem. 269:19725-19730.
102. Leidich, S. B., A. S. Ibrahim, Y. Fu, A. Koul, C. Jessup, J. Vitullo, W. Fonzi, F. Mirbod, S. Nakashima, Y. Nozawa, and M. A. Ghannoum. 1998. Cloning and disruption of caPLB1, a phospholipase B gene involved in the pathogenicity of Candida albicans. J. Biol. Chem. 273:26078-26086.
103. Leimeister-Wachter, M., E. Domann, and T. Chakraborty. 1991. Detection of a gene encoding a phosphatidylinositol-specific phospholipase C that is co-ordinately expressed with listeriolysin in Listeria monocytogenes. Mol. Microbiol. 5:361-366.
104. Leslie, D., N. Fairweather, D. Pickard, G. Dougan, and M. Kehoe. 1989. Phospholipase C and haemolytic activities of Clostridium perfringens alpha-toxin cloned in Escherichia coli: sequence and homology with a Bacillus cereus phospholipase C. Mol. Microbiol. 3:383-392.
105. Little, C., B. Aurebekk, and A.-B. Otnaess. 1975. Purification by affinity chromatography of phospholipase C from Bacillus cereus. FEBS Lett. 52: 175-179.
106. Liu, P. 1979. Toxins of Pseudomonas aeruginosa, p. 63-68. In R. G. Dogget. (ed.), Pseudomonas aeruginosa: clinical manifestations of infection and current therapy. Academic Press, Inc., New York, N.Y.
107. Long-Krug, S., K. Fischer, R. Hysmith, and J. Ravdin. 1985. Phospholipase A enzymes of Entamoeba histolytica: description and subcellular localization. J. Infect. Dis. 152:536-541.
108. Lu, C. F., J. Kurjan, and P. N. Lipke. 1994. A pathway for cell wall anchorage of Saccharomyces cerevisiae alpha-agglutinin. Mol. Cell. Biol. 14:4825-4833.
109. Lu, C. F., R. C. Montijn, J. L. Brown, F. Klis, J. Kurjan, H. Bussey, and P. N. Lipke. 1995. Glycosyl phosphatidylinositol-dependent cross-linking of α-agglutinin and β-1,6-glucan in the Saccharomyces cerevisiae cell wall. J. Cell Biol. 128:333-340.
110. MacFarlane, M. G. 1955. On the biochemical mechanisms of action of gas-gangrene toxins, p. 57-77. In J. W. Howie and A. J. Ollea (ed.), Mechanisms of microbial pathogenicity. Cambridge University Press, Cambridge, United Kingdom.
111. MacFarlane, M. G., and B. C. J. G. Knight. 1941. The biochemistry of bacterial toxins. I. Lecithinase activity of Cl. welchii toxins. Biochem. J. 35:884-902.
112. Marck, C. 1988. 'DNA Strider': a 'C' program for the fast analysis of DNA and protein sequences on the Apple Macintosh family of computers. Nucleic Acids Res. 16:1829-1836.
113. Martinez, J. P., M. L. Gil, J. L. Lopez-Ribot, and W. L. Chaffin. 1998. Serologic response to cell wall mannoproteins and proteins of Candida albicans. Clin. Microbiol. Rev. 11:121-141.
114. Masuda, N., N. Kitamura, and K. Saito. 1991. Primary structure of protein moiety of Penicillium notatum phospholipase B deduced from the cDNA. Eur. J. Biochem. 202:783-787.
115. May, A. K., R. G. Sawyer, T. Gleason, A. Whitworth, and T. L. Pruett. 1996. In vivo cytokine response to Escherichia coli alpha-hemolysin determined with genetically engineered hemolytic and nonhemolytic E. coli variants. Infect. Immun. 64:2167-2171.
116. McDonel, J. L. 1986. Toxins of Clostridium perfringens types A, B, C, D, and E, p. 477-517. In F. Dorner and J. Drews (ed.), Pharmacology of bacterial toxins. Pergamon Press, Oxford, United Kingdom.
117. McLain, N., and J. W. Dolan. 1997. Phospholipase D activity is required for dimorphic transition in Candida albicans. Microbiology 143:3521-3526.
118. McNamara, P. J., G. A. Bradley, and J. G. Songer. 1994. Targeted mutagenesis of the phospholipase D gene results in decreased virulence of Corynebacterium pseudotuberculosis. Mol. Microbiol. 12:921-930.
119. McNamara, P. J., W. A. Cuevas, and J. G. Songer. 1995. Toxic phospholipases D of Corynebacterium pseudotuberculosis, C. ulcerans and Arcanobacterium haemolyticum: cloning and sequence homology. Gene 156: 113-118.
120. Mengaud, J., C. Barun-Breton, and P. Cossart. 1991. Identification of a phosphatidylinositol-specific phospholipase C in Listeria monocytogenes: a novel type of virulence factor? Mol. Microbiol. 5:367-372.
121. Meyers, D. J., and R. S. Berk. 1990. Characterization of phospholipase C from Pseudomonas aeruginosa as a potent inflammatory agent. Infect. Immun. 58:659-666.
122. Reference deleted.
123. Mirbod, F., Y. Banno, M. A. Ghannoum, A. S. Ibrahim, S. Nakashima, Y. Kitajima, G. T. Cole, and Y. Nozawa. 1995. Purification and characterization of lysophospholipase-transacylase (h-LPTA) from a highly virulent strain of Candida albicans. Biochim. Biophys. Acta 1257:181-188.
124. Mitsui, K., N. Mitsui, and J. Hase. 1973. Clostridium perfringens exotoxins. I. Purification and properties of the α-toxin. Jpn. J. Exp. 43:65-80.
125. Montes, L. F., and W. H. Wilborn. 1981. Ultrastructural features of host-parasite relationship in oral candidiasis. J. Bacteriol. 96:1349-1356.
126. Morris, A. J., J. Engebrecht, and M. A. Frohman. 1996. Structure and regulation of phospholipase D. Trends Pharmacol. Sci. 17:182-185.
127. Möllby, R. 1978. Bacterial phospholipases, p. 367-424. In J. Jeljaszewicz and T. Wadström, (ed.), Bacterial toxins and cell membranes. Academic Press, Inc., New York, N.Y.
128. Möllby, R., C. E. Nord, and T. Wadstrom. 1973. Biological activities contaminating preparations of phospholipase C (α-toxin) from Clostridium perfringens. Toxicon 11:139-147.
129. Reference deleted.
130. Reference deleted.
131. Nakashima, S., Y. Matsuda, Y. Akao, S. Yoshimura, H. Sakai, K. Hayakawa, M. Andoh, and Y. Nozawa. 1997. Molecular cloning and chromosome mapping of rat phospholipase D genes, Pld1a, Pld1b and Pld2. Cytogenet. Cell Genet. 79:109-113.
132. Odds, F. 1988. Candidosis of the gastrointestinal tract, p. 156-163. In Candida and candidosis. Bailliere Tindall, London, United Kingdom.
133. Odds, F., and A. Abbott. 1980. A simple system for presumptive identification of Candida albicans and differentiation of strains within the species. Sahouraudia 18:301-307.
134. Odds, F. C. 1994. Candida species and virulence. ASM News 60:313-318.
135. Ohsaka, A., M. Tsuchiya, C. Oshio, M. Miyari, K. Suzuki, and Y. Yamakawa. 1978. Aggregation of platelets in the mesenteric microcirculation of the rat induced by α-toxin (phospholipase C) of Clostridium perfringens. Toxicon 16:333-341.
136. Oishi, K., R. L. Raynor, P. A. Charp, and J. F. Kuo. 1988. Regulation of protein kinase C by lysophospholipids. Potential role in signal transduction. J. Biol. Chem. 263:6865-6871.
137. Okabe, A., T. Shimizu, and H. Hayashi. 1989. Cloning and sequencing of a phospholipase C gene of Clostridium perfringens. Biochem. Biophys. Res. Commun. 160:33-39.
138. Ostroff, R. M., A. I. Vasil, and M. L. Vasil. 1990. Molecular comparison of a nonhemolytic and a hemolytic phospholipase C from Pseudomonas aeruginosa. J. Bacteriol. 172:5915-5923.
139. Ostroff, R. M., B. Wretlind, and M. L. Vasil. 1989. Mutations in the hemolytic-phospholipase C operon result in decreased virulence of Pseudomonas aeruginosa PAO1 grown under phosphate-limiting conditions. Infect. Immun. 57:1369-1373.
140. Perfect, J. R. 1996. Fungal virulence genes as targets for antifungal chemotherapy. Antimicrob. Agents Chemother. 40:1577-1583.
141. Pfaller, M., and R. Wenzel. 1992. Impact of the changing epidemiology of fungal infections in the 90's. Eur. J. Clin. Microbiol. Infect. Dis. 11:287-291.
142. Pfaller, M. A., J. Zhang, S. A. Messer, M. E. Brandt, R. A. Hajjeh, and C. J. Jessup. 1998. In vitro activities on voriconazole, fluconazole, and itraconazole against 566 clinical isolates of Cryptococcus neoformans from the United States and Africa. Antimicrob. Agents Chemother. 43:169-171.
143. 2. J. Biol. Chem. 271:19225-19231.
144. Pittet, D., D. Tarrara, and R. P. Wenzel. 1985. Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs, and attributable mortality, p. 17-24. In J. Rex and M. D. Anderson (ed.), Serious Candida Infections: risk factors, treatment, and prevention. Selected readings: focus on fluconazole. Medical Information Press, Pfizer, Inc., New York, N.Y.
145. Portnoy, D. A. 1994. Cellular biology of Listeria monocytogenes infection, p. 279-293. In V. L. Miller, J. B. Kaper, D. A. Portnoy, and R. R. Isberg (ed.), Molecular genetics of bacterial pathogenesis. American Society for Microbiology, Washington, D.C.
146. Prakobphol, A., H. Leffler, and S. J. Fisher. 1998. Specific adherence of Candida tropicalis to lysophospholipids. Biochemistry 33:9496-9503.
147. Price, M. F., M. T. LaRocco, and L. O. Gentry. 1994. Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period. Antimicrob. Agents Chemother. 38: 1422-1424.
148. Price, M. F., I. D. Wilkinson, and L. O. Gentry. 1982. Plate method for detection of phospholipase activity in Candida albicans. Sabouraudia 20:7-14.
149. Projan, S. J., J. Kornblum, B. Kreiswirth, S. L. Moghazeh, W. Eiser, and R. P. Novick, 1989. Nucleotide sequence of the β-hemolysin gene of Staphylococcus aureus. Nucleic Acids Res. 17:3305.
150. Pugh, D., and R. A. Cawson. 1977. The cytochemical localization of phospholipase in Candida albicans infecting the chick chorio-allantoic membrane. Sabouraudia 15:29-35.
151. Pugh, D., and R. A. Cawson. 1975. The cytochemical localization of phospholipase A and lysophospholipase in Candida albicans. Sabouraudia 13: 110-115.
152. Qin, W., K. Pappan, and X. Wang. 1997. Molecular heterogeneity of phospholipase D (PLD): cloning of PLDγ and regulation of plant PLDγ, -β, and -α by polyphosphoinositides and calcium. J. Biol. Chem. 272:28267-28273.
153. Rahmet-Alla, M., and A. F. Rowley. 1990. Studies on the cellular defense reactions of the madeira cockroach, Leucophaea maderae: in vitro phagocytosis of different strains of Bacillus cereus and their effect on hemocyte viability. J. Invertebr. Pathol. 55:350-356.
154. Ravdin, J., C. Murphy, R. Guerrant, and S. Long-Krug. 1985. Effect of antagonists of calcium and phospholipase A on the cytopathogenicity of E. histolytica. J. Infect. Dis. 152:542-549.
155. Ravdin, J. I., B. Y. Croft, and R. L. Guerrant. 1998. Cytopathogenic mechanisms of Entamoeba histolytica. J. Exp. Med. 152:377.
156. Reiss, E., and C. J. Morrison. 1993. Nonculture methods for diagnosis of disseminated candidiasis. Clin. Microbiol. Rev. 6:311-323.
157. Rex, J. H., J. E. Bennett, A. M. Sugar, P. G. Pappas, C. M. van der Horst, J. E. Edwards, et al. 1994. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. N. Engl. J. Med. 331:1325-1330.
158. Rogolsky, M. 1979. Nonenteric toxins of Staphylococcus aureus. Microbiol. Rev. 43:320-360.
159. Rose, K., S. A. Rudge, M. A. Frohman, A. J. Morris, and J. Engebrecht. 1995. Phospholipase D signaling is essential for meiosis. Proc. Natl. Acad. Sci. USA 92:12151-12155.
160. Rosenberg, P. 1976. Bacterial and snake venom phospholipases: enzymatic probes in the study of structure and function in bioelectrically excitable tissues, p. 229-262. In A. Ohsaka, K. Hayashi, and Y. Sawai (ed.), Animal, plant, and microbial toxins, vol. 2. Plenum Press, New York, N.Y.
161. Saffer, L. D., S. A. L. Krug, and J. D. Schwartzman. 1989. The role of phospholipase in host cell penetration by Toxoplasma gondii. Am. J. Trop. Med. Hyg. 40:145-149.
162. Saffer, L. D., and J. D. Schwartzman. 1991. A soluble phospholipase of Toxoplasma gondii associated with host cell penetration. J. Protozool. 38: 454-460.
163. Saint-Joanis, B., T. Garnier, and S. Cole. 1989. Gene cloning shows the alpha-toxin of Clostridium perfringens to contain both sphingomyelinase and lecithinase activities. Mol. Gen. Genet. 219:453-460.
164. Saito, K., and M. Kates. 1974. Substrate specificity of a highly purified phospholipase B from Penicillium notatum. Biochim. Biophys. Acta 369: 245-253.
165. Saito, K., J. Sugatani, and T. Okumura. 1991. Phospholipase B from Penicillium notatum. Methods Enzymol. 197:446-456.
166. Saitou, N., and M. Nei. 1987. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4:406-425.
167. Salyers, A., and D. Witt. 1994. Virulence factors that damage the host, p. 47-62. In A. Salyers and D. Witt (ed.), Bacterial pathogenesis: a molecular approach. ASM Press, Washington, D.C.
168. Salyers, A., and D. Witt. 1994. Virulence factors that promote colonization, p. 30-46. In A. Salyers and D. Witt (ed.), Bacterial pathogenesis: a molecular approach. ASM Press, Washington, D.C.
169. Samaranayake, L. P., J. M. Raeside, and T. W. MacFarlane. 1984. Factors affecting the phospholipase activity of Candida species in vitro. Sabouraudia 22:201-207.
170. Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463-5467.
171. Sanglard, D., B. Hube, M. Monod, F. Odds, and N. A. R. Gow. 1997. A triple deletion of the secreted aspartyl proteinase genes SAP4, SAP5, and SAP6 of Candida albicans causes attenuated virulence. Infect. Immun. 65:3539-3546.
172. Scherwitz, C. 1982. Ultrastructure of human cutaneous candidosis. J. Investig. Dermatol. 78:200-205.
173. Selik, R. M., E. T. Starcher, and J. W. Curran. 1987. Opportunistic diseases reported in AIDS patients: frequencies, association, and trends. AIDS 1:175-182.
174. Serhan, C. N., J. Z. Haeggstrom, and C. C. Leslie. 1996. Lipid mediator networks in cell signaling: update and impact of cytokines. FASEB J. 10:1147-1158.
175. Seshan, K. R., J. C. Vitullo, S. D. Leidich, C. Jessup, G. T. Cole, and M. A. Ghannoum. A genetically defined phospholipase B-deficient Candida albicans mutant is less virulent in the oral-intragastric infant mouse model. Submitted for publication.
176. Sheehan, D. J., C. A. Hitchcock, and C. M. Sibley. 1999. Current and emerging azole antifungal agents. Clin. Microbiol. Rev. 12:40-79.
177. Shimizu, S., Y. Tani, H. Yamada, M. Tabata, and T. Murachi. 1980. Enzymatic determination of serum-free fatty acids: a colorimetric method. Anal. Biochem. 107:193-198.
178. Silverman, D. J., L. A. Santucci, N. Meyers, and Z. Sekeyova. 1992. Penetration of host cells by Rickettsia rickettsii appears to be mediated by a phospholipase of rickettsial origin. Infect. Immun. 60:2733-2740.
179. Smith, G. A., H. Marquis, S. Jones, N. C. Johnston, D. A. Portnoy, and H. Goldfine. 1995. The two distinct phospholipase C of Listeria monocytogenes have overlapping roles in escape from a vacuole and cell-to-cell spread. Infect. Immun. 63:4231-4237.
180. Smith, L. D. S. 1979. Virulence factors of Clostridium perfringens. Rev. Infect. Dis. 1:254-262.
181. Soll, D. 1985. Candida albicans, p. 167-195. In P. Szaniszlo (ed.), Fungal dimorphism with emphasis on fungi pathogenic to humans. Plenum Press, New York, N.Y.
182. Soll, D. 1992. High-frequency switching in Candida albicans. Clin. Microbiol. Rev. 5:183-203.
183. Soll, D. R. 1997. Gene regulation during high frequency switching in Candida albicans. Microbiology 143:279-288.
184. Songer, J. G. 1997. Bacterial phospholipases and their role in virulence. Trends Microbiol. 5:156-161.
185. Soucek, A., C. Michalec, and A. Souckova. 1971. Identification and characterization of a new enzyme of the group 'phospholipase D' isolated from Corynebacterium ovis. Biochim. Biophys. Acta 227:116-128.
186. Sugahara, T., T. Takahashi, S. Yamaya, and A. Ohsaka. 1976. In vitro aggregation of platelets induced by α-toxin (phospholipase C) of Clostridium perfringens. Jpn. J. Med. Sci. Biol. 29:255-263.
187. Sugahara, T., T. Takahashi, S. Yamaya, and A. Ohsaka. 1977. Vascular permeability increase by α-toxin (phospholipase C) of Clostridium perfringens. Toxicon 15:81-87.
188. Sugimoto, H., and S. Yamashita. 1994. Purification, characterization, and inhibition by phosphatidic acid of lysophospholipase transacylase from rat liver. J. Biol. Chem. 269:6252-6258.
189. Sugiyama, Y., S. Nakashima, F. Mirbod, H. Kanoh, Y. Kitajima, M. A. Ghannoum, and Y. Nozawa. 1999. Molecular cloning of a second phospholipase B gene, caPLB2 from Candida albicans. Med. Mycol. 37:61-67.
190. Sung, T.-C., R. L. Roper, Y. Zhang, S. A. Rudge, R. Temel, S. M. Hammond, A. J. Morris, B. Moss, J. Engebrecht, and M. A. Frohman. 1997. Mutagenesis of phospholipase D defines a super-family including a trans-Golgi viral protein required for pox-virus pathogenicity. EMBO J. 16:4519-4530.
191. Swenson, C. E., W. R. Perkins, P. Roberts, I. Ahmad, R. Stevens, D. A. Stevens, and A. S. Janoff. 1998. In vitro and in vivo antifungal activity of amphotericin B lipid complex: are phospholipases important? Antimicrob. Agents Chemother. 42:767-771.
192. Taguchi, R., and H. Ikezawa. 1975. Phospholipase C from Clostridium novyi type A.I. Biochim. Biophys. Acta 409:75-85.
193. Taguchi, R., and H. Ikezawa. 1978. Phosphatidylinositol-specific phospholipase C from Clostridium novyi type A. Arch. Biochem. Biophys. 186:196-201.
194. Takahashi, M., Y. Banno, and Y. Nozawa. 1991. Secreted Candida albicans phospholipases: purification and characterization of two forms of lysophospholipase-transacylase. J. Med. Vet. Mycol. 29:193-204.
195. Titball, R. W. 1993. Bacterial phospholipases C. Microbiol. Rev. 57:347-366.
196. Titball, R. W., S. E. C. Hunter, K. L. Martin, B. C. Morris, A. D. Shuttleworth, T. Rubidge, D. W. Anderson, and D. C. Kelly. 1989. Molecular cloning and nucleotide sequence of the alpha-toxin (phospholipase C) of Clostridium perfringens. Infect. Immun. 57:367-376.
197. Titball, R. W., D. L. Leslie, S. Harvey, and D. Kelly. 1991. Haemolytic and sphingomyelinase activities of Clostridium perfringens alpha-toxin are dependent on a domain homologous to that of an enzyme from the human arachidonic acid pathway. Infect. Immun. 59:1872-1874.
198. Tso, J. Y., and C. Siebel. 1989. Cloning and expression of the phospholipase C gene from Clostridium perfringens and Clostridium bifermentans. Infect. Immun. 57:468-476.
199. Turnbull, P. C., J. Kramer, and J. Melling. 1990. Bacillus, p. 188-210. In W. W. C. Topley and G. S. Wilson (ed.), Topley and Wilson's principles of bacteriology, virology and immunity, vol. 2, 8th ed. Edward Arnold, London, United Kingdom.
200. Turnbull, P. C. B. 1986. Bacillus cereus toxins, p. 397-448. In F. Dorner and J. Drews (ed.), Pharmacology of bacterial protein toxins. Permagon Press, New York, N.Y.
201. 2 expression and inflammation: the relationship with associated disease states. J. Lipid Mediators 8:1-30.
202. Vanden Bossche, H., H. P. Marichal, F. Odds, L. Le Jeune, and M.-C. Coene. 1992. Characterization of an azole-resistant Candida glabrata isolate. Antimicrob. Agents Chemother. 36:2602-2610.
203. Vasil, M. L., D. P. Krieg, J. S. Kuhns, J. W. Ogle, V. D. Shortridge, R. M. Ostroff, and A. I. Vasil. 1990. Molecular analysis of haemolytic and phospholipase C activities of Pseudomonas cepacia. Infect. Immun. 58:4020-4029.
204. Vazquez-Boland, J. A., C. Kocks, S. Dramsi, H. Ohayon, C. Geoffroy, J. Mengaud, and P. Cossart. 1992. Nucleotide sequence of the lecithinase operon of Listeria monocytogenes and possible role of lecithinase in cell-to-cell spread. Infect. Immun. 60:219-230.
205. Vidotto, V., A. Sinicco, D. Di Fraia, S. Cardaropoli, S. Aoki, and S. Ito-Kuwa. 1997. Phospholipase activity in Cryptococcus neoformans. Mycopathologia 136:119-123.
206. Reference deleted.
207. Waksman, M., Y. Eli, M. Liscovitch, and J. E. Gerst. 1998. Identification and characterization of a gene encoding phospholipase D activity in yeast. J. Biol. Chem. 271:2361-2364.
208. Walker, D. H., W. T. Firth, J. G. Ballard, and B. C. Hegarty. 1983. Role of phospholipase-associated penetration mechanism in cell injury by Rickettsia rickettsii. Infect. Immun. 40:840-842.
209. Walker, T. S., J. S. Brown, C. S. Hoover, and D. A. Morgan. 1990. Endothelial prostaglandin secretion: effects of typhus rickettsiae. J. Infect. Dis. 162:1136-1144.
210. Wang, X., L. Xu, and L. Xheng. 1994. Cloning and expression of phosphatidylcholine-hydrolyzing phospholipase D from Ricinus communis L. J. Biol. Chem. 269:20312-20317.
211. Reference deleted.
212. Watanabe, Y., Y. Yashiki, G. N.-N. Sultana, M. Maruyama, K. Kangawa, and Y. Tamai. 1994. Cloning and sequencing of phospholipase B gene from the yeast Torulaspora delbrueckii. FEMS Microbiol. Lett. 124:29-34.
213. Wazny, T. K., N. Mummaw, and B. Styrt. 1990. Degranulation of human neutrophils after exposure to bacterial phospholipase C. Eur. J. Clin. Microbiol. Infect. Dis. 9:830-832.
214. Werner, H. 1966. Untersuchungen uber die Lipase-Aktivitat bei Hefen und Hefeahnlichen Pilzen. Zentbl. Bakteriol. Mikrobiol. Hyg. 1 Abt Orig. A 200:113.
215. Wickerham, L. J. 1957. Apparent increase in frequency of infections involving Torulopsis glabrata: procedure for its identification. JAMA 165:47-48.
216. Williamson, E. D., and R. W. Titball. 1993. A genetically engineered vaccine against α-toxin of Clostridium perfringens protects mice against experimental gas gangrene. Vaccine 11:1253-1258.
217. Williamson, M. I., L. P. Samaranayake, and T. W. MacFarlane. 1986. Phospholipase activity as a criterion for biotyping Candida albicans. J. Med. Vet. Mycol. 24:415-417.
218. Willis, T. A. 1969. Clostridia of wound infection. Butterworths, London, United Kingdom.
219. Willis, T. A. 1977. Anaerobic bacteriology: clinical and laboratory practice, 3rd ed. Butterworths, London, United Kingdom.
220. Wingard, J. R. 1995. Importance of Candida species other than C. albicans as pathogens in oncology patients. Clin. Infect. Dis. 20:115-125.
221. Wingard, J. R., W. G. Merz, M. G. Rinaldi, C. B. Miller, J. E. Karp, and R. Saral. 1993. Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients. Antimicrob. Agents Chemother. 37:1847-1849.
222. Winkler, H., and E. Miller. 1980. Phospholipase A activity in the hemolysis of sheep and human erythrocytes by Rickettsia prowazekii. Infect. Immun. 29:316-321.
223. Winkler, H., and E. Miller. 1981. Immediate cytotoxicity and phospholipase A: the role of phospholipase in the internalization of Rickettsia prowazekii and L-cells, p. 327-333. In W. Burgdorfer and R. Anacker (ed.), Proceedings of the Rocky Mountain Laboratory Conference on Rickettsiae and Rickettsial Diseases. Academic Press, Inc., New York, N.Y.
224. Winkler, H. H. 1986. Early events in the interaction of the obligate intracytoplasmic parasite, Rickettsia prowazekii, with eucaryotic cells: entry and lysis. Ann. Inst. Pasteur Microbiol. 137A:333-336.
225. Witt, W., H.-J. Bruller, G. Falker, and G. F. Fuhrmann. 1982. Purification and properties of a phospholipid acyl hydrolase from plasma membranes of Saccharomyces cerevisiae. Biochim. Biophys. Acta 711:403-410.
226. Witt, W., A. Mertsching, and E. Konig. 1984. Secretion of phospholipase B from Saccharomyces cerevisiae. Biochim. Biophys. Acta 795:117-124.
227. Witt, W., M. E. Schweingruber, and A. Mertsching. 1984. Phospholipase B from the plasma membrane of Saccharomyces cerevisiae. Separation of two forms with different carbohydrate content. Biochim. Biophys Acta 795: 108-116.
228. Wysong, D. R., L. Christin, A. M. Sugar, P. W. Robbins, and R. D. Diamond. 1998. Cloning and sequencing of a Candida albicans catalase gene and effects of disruption of this gene. Infect. Immun. 66:1953-1961.
229. Yun Tso, J., and C. Siebel. 1989. Cloning and expression of the phospholipase C gene from Clostridium perfringens and Clostridium bifermentans. Infect. Immun. 57:468-476.
230. Zhao, X. J., G. E. McElhaney-Feser, M. J. Sheridan, and S. E. Broedel, Jr. 1997. Avirulence of Candida albicans FAS2 mutants in a mouse model of systemic candidiasis. Infect. Immun. 65:829-832.
231. Zwaal, R. F. A., B. Roelofsen, and C. M. Colley. 1973. Localization of red cell membrane constituents. Biochim. Biophys. Acta 300:159-182.